Oct 26, 2026 | Acquisition Cost Index (ACI) pricing, Consolidated Appropriations Act of 2026 (CAA), Department of Labor, Formularies, High-value formulary, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Transparency
Federal reforms are putting plan sponsors’ oversight duties in sharper focus. The 2026 Consolidated Appropriations Act (signed February 3) adds PBM reporting rules that cover drug spending, pass-through rebates, and vendor compensation. Major provisions will generally...
Oct 13, 2026 | Alternate Rx sourcing, Biosimilars, Drug costs, High-value formulary, MedBen Rx, Over-the-counter (OTC) drugs, Patient assistance, Specialty Drugs, Spending
Self-funded pharmacy plans rarely have just one cost concern. High-cost brands, combination products, specialty medications, and prescriptions that could be handled over the counter can all drive spending in different ways. Solutions exist, but many PBMs rely on...
Jan 12, 2026 | Acquisition Cost Index (ACI) pricing, Biosimilars, Brand Name Drugs, Drug costs, High-value formulary, MedBen Rx, News, Patient assistance, Pharmacogenomics, Pharmacy
Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...
Aug 26, 2025 | Client Report, Cost management, Cost projections, Cost Savings, Direct-to-Employer Contracting, Drug costs, Health care costs, High-value formulary, Rx Costs, Savings, Wellness
A new national survey on employer health care strategies finds that employees are likely to see higher premiums and out-of-pocket costs in the years ahead, as overall health care expenses continue to rise. But for self-funded employers, asking employees to shoulder...
Jul 11, 2025 | Cost Savings, Drug advertising, Drug costs, Health care costs, High-value formulary, MedBen Rx, Pharmacy, Rx Costs, Spending
Pharmaceutical advertising hit a record high in 2024, with the top 10 drugs accounting for $3.3 billion in ad spending – up nearly 20% from the previous year. With more campaigns directly targeting consumers, MedBen Rx’s high-value formulary educates members about...